antineoplaston a10 has been researched along with Cancer of Prostate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, SW; Kim, AR; Kim, DI; Lee, JY; Shin, SW; Um, SH | 1 |
Abnous, K; Danesh, NM; Ramezani, M; Sarreshtehdar Emrani, A; Tabrizian, K; Taghdisi, SM; Zandkarimi, M | 1 |
2 other study(ies) available for antineoplaston a10 and Cancer of Prostate
Article | Year |
---|---|
A light-driven anti-cancer dual-therapeutic cassette enhances solid tumour regression.
Topics: Animals; Antibiotics, Antineoplastic; Benzeneacetamides; Cell Line; Cell Survival; DNA; Doxorubicin; Drug Design; Gold; Humans; Hyperthermia, Induced; Light; Male; Metal Nanoparticles; Mice; Mice, Nude; Nanoparticles; Piperidones; Prostatic Neoplasms; RNA; Transplantation, Heterologous | 2013 |
Targeted delivery of Epirubicin to cancer cells by PEGylated A10 aptamer.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Aptamers, Nucleotide; Benzeneacetamides; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Epirubicin; Humans; Male; Piperidones; Polyethylene Glycols; Prostatic Neoplasms | 2013 |